XmAb®5871

· Xencor, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XmAb®5871, covering 2018-12-07 to 2019-08-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus [Phase 2]